Human umbilical cord mesenchymal stromal cells attenuate pulmonary fibrosis via regulatory T cell through interaction with macrophage

Abstract

Background Pulmonary fibrosis (PF) is a growing clinical problem with limited therapeutic options. Human umbilical cord mesenchymal stromal cell (hucMSC) therapy is being investigated in clinical trials for the treatment of PF patients. However, little is known about the underlying molecular and cellular mechanisms of hucMSC therapy on PF. In this study, the molecular and cellular behavior of hucMSC was investigated in a bleomycin-induced mouse PF model. Methods The effect of hucMSCs on mouse lung regeneration was determined by detecting Ki67 expression and EdU incorporation in alveolar type 2 (AT2) and lung fibroblast cells. hucMSCs were transfected to express the membrane localized GFP before transplant into the mouse lung. The cellular behavior of hucMSCs in mouse lung was tracked by GFP staining. Single cell RNA sequencing was performed to investigate the effects of hucMSCs on gene expression profiles of macrophages after bleomycin treatment. Results hucMSCs could alleviate collagen accumulation in lung and decrease the mortality of mouse induced by bleomycin. hucMSC transplantation promoted AT2 cell proliferation and inhibited lung fibroblast cell proliferation. By using single cell RNA sequencing, a subcluster of interferon-sensitive macrophages (IFNSMs) were identified after hucMSC infusion. These IFNSMs elevate the secretion of CXCL9 and CXCL10 following hucMSC infusion and recruit more Treg cells to the injured lung. Conclusions Our study establishes a link between hucMSCs, macrophage, Treg, and PF. It provides new insights into how hucMSCs interact with macrophage during the repair process of bleomycin-induced PF and play its immunoregulation function.

WITHDRAWN: The Role of the Vascular Niche in Organ Fibrosis and COVID-19-Related Organ Damage and the Countermeasures adopted by Chinese and Western Medicine

“…In addition, the exosomal miR-34c-5p derived from MSCs in the kidney can enter pericytes to modulate multiple pro-fibrotic signaling pathways, such as TGFβ/Smad3 and PDGF-BB/PI3K/ERK, and alter pericyte phenotypes by inhibiting core fucosylation (CF) [78] . Transplanted MSCs also promoted type 2 alveolar cell proliferation, attenuated macrophage infiltration, and inhibited lung fibroblast proliferation [79] . The above studies provide a new direction for antifibrotic therapy.…”

Shikonin regulates autophagy via the AMPK/mTOR pathway and reduces apoptosis of human umbilical cord mesenchymal stem cells to improve survival in tissues surrounding brain contusion

“…HUMSCs with GFP protein gene emitting green fluorescence were found in brain tissue surrounding the TBI, suggesting that transplanted HUMSCs were able to survive and migrate to the site of injury ( 41 ). In addition, the GFP from HUMSCs was significantly increased 7 days after transplantation in the shikonin-pretreated group compared with HUMSCs alone (shikonin + TBI vs. TBI group, P<0.01; shikonin + TBI vs. shikonin + TBI + 3-MA group, P<0.05; Fig.…”

Therapeutic Potential of Human Umbilical Cord-Derived Mesenchymal Stem Cells in Recovering From Murine Pulmonary Emphysema Under Cigarette Smoke Exposure

“…For example, higher lymphocyte counts were more efficient in activating MSCs in the treatment of graft vs. host disease ( 45 ). A previous study showed that that hUC-MSCs recruited the regulatory T cells in the damaged lung ( 46 ). Together, hUC-MSCs could regulate lung neutrophil infiltration and lymphocyte activation in emphysematous mice.…”